Akzo Nobel NV

Akzo Nobel rejects €73‑per‑share takeover bid, reaffirming its growth and merger plans with Axalta while boosting investor confidence in its diversified chemical portfolio.

Akzo Nobel NV reported a mixed second quarter performance, with weaker-than-expected earnings and revenue decline, amidst broader market uncertainty and trade tensions.